Survival benefit with kidney transplants from HLA-incompatible live donors

New England Journal of Medicine

Volumn 374, Issue 10, 2016, Pages 940-950

  Orandi, B J ^a   Luo, X ^a   Massie, A B ^a   Garonzik Wang, J M ^b   Lonze, B E ^a   Ahmed, R ^a   Van Arendonk, K J ^a   Stegall, M D ^c   Jordan, S C ^e   Oberholzer, J ^e   Dunn, T B ^d   Ratner, L E ^j   Kapur, S ^k   Pelletier, R P ^l   Roberts, J P ^f   Melcher, M L ^g   Singh, P ^h   Sudan, D L ^q   Posner, M P ^s   El Amm, J M ^t   Shapiro, R ^p   Cooper, M ^u   Lipkowitz, G S ^v   Rees, M A ^m   Marsh, C L ^h   Sankari, B R ⁿ   Gerber, D A ^r   Nelson, P W ^o   Wellen, J ⁱ   Bozorgzadeh, A ^w   Gaber, A O ^x,y   Montgomery, R A ^a   Segev, D L ^a   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e Department of Hematology Oncology Cedars Sinai Comprehensive Cancer Center   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g STANFORD UNIVERSITY   (United States)

^h SCRIPPS CLINIC   (United States)

ⁱ UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^j NewYork Presbyterian Hospital   (United States)

^k WEILL CORNELL MEDICAL CENTER   (United States)

^l OHIO STATE UNIVERSITY   (United States)

^m UNIVERSITY OF TOLEDO MEDICAL CENTER   (United States)

ⁿ LERNER RESEARCH INSTITUTE   (United States)

^o THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^p UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^q DUKE UNIVERSITY MEDICAL CENTER   (United States)

^r UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^s VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^t INTEGRIS BAPTIST MEDICAL CENTER   (United States)

^u GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^v BAYSTATE MEDICAL CENTER   (United States)

^w UMASS MEMORIAL MEDICAL CENTER   (United States)

^x St Vincent Hospital   (United States)

^y HOUSTON METHODIST HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DONOR; ETHNIC DIFFERENCE; EXTERNAL VALIDITY; FEMALE; FLOW CYTOMETRY; GRAFT SURVIVAL; HISTOINCOMPATIBILITY; HLA INCOMPATIBLE LIVE DONOR; HLA MATCHING; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; UNITED STATES; VALIDATION PROCESS; CLINICAL TRIAL; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TEST; HOSPITAL ADMISSION; LIVING DONOR; MORTALITY; MULTICENTER STUDY; SURVIVAL; TRANSPLANTATION;

HLA ANTIGEN;

GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 84960466211     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1508380     Document Type: Article

References (40)

1. Scientific Registry of Transplant Recipients home page (http://www.srtr .org/).
2. Annual report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant data 1999-2008 (http://www.srtr .org/annual-reports/archives/2009/2009-Annual-Report/).
3. Fuggle SV, Martin S. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation 2008; 86: 384-90.
4. Segev DL, Gentry SE, Warren DS, Reeb B, Montgomery RA. Kidney paired donation and optimizing the use of live donor organs. JAMA 2005; 293: 1883-90.
5. Blumberg JM, Gritsch HA, Reed EF, et al. Kidney paired donation in the presence of donor-specific antibodies. Kidney Int 2013; 84: 1009-16.
6. Gentry SE, Segev DL, Simmerling M, Montgomery RA. Expanding kidney paired donation through participation by compatible pairs. Am J Transplant 2007; 7: 2361-70.
7. Massie AB, Gentry SE, Montgomery RA, Bingaman AA, Segev DL. Center-level utilization of kidney paired donation. Am J Transplant 2013; 13: 1317-22.
8. Montgomery RA, Simpkins CE, Segev DL. New options for patients with donor incompatibilities. Transplantation 2006; 82: 164-5.
9. Montgomery RA, Zachary AA, Ratner LE, et al. Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation. JAMA 2005; 294: 1655-63.
10. Glotz D, Antoine C, Julia P, et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant 2002; 2: 758-60.
11. Haririan A, Nogueira J, Kukuruga D, et al. Positive cross-match living donor kidney transplantation: longer-Term outcomes. Am J Transplant 2009; 9: 536-42.
12. Gloor JM, DeGoey SR, Pineda AA, et al. Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 2003; 3: 1017-23.
13. Higgins R, Lowe D, Hathaway M, et al. Human leukocyte antigen antibodyincompatible renal transplantation: excellent medium-Term outcomes with negative cytotoxic crossmatch. Transplantation 2011; 92: 900-6.
14. Jordan SC, Tyan D, Stablein D, et al. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol 2004; 15: 3256-62.
15. Ejaz NS, Shields AR, Alloway RR, et al. Randomized controlled pilot study of B cell-Targeted induction therapy in HLA sensitized kidney transplant recipients. Am J Transplant 2013; 13: 3142-54.
16. Magee CC, Felgueiras J, Tinckam K, Malek S, Mah H, Tullius S. Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one centers experience. Transplantation 2008; 86: 96-103.
17. Montgomery RA. Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols. Am J Transplant 2010; 10: 449-57.
18. Montgomery RA, Lonze BE, Jackson AM. Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients. Curr Opin Organ Transplant 2011; 16: 439-43.
19. Montgomery RA, Lonze BE, King KE, et al. Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med 2011; 365: 318-26.
20. Montgomery RA, Zachary AA. Transplanting patients with a positive donorspecific crossmatch: A single centers perspective. Pediatr Transplant 2004; 8: 535-42.
21. Schweitzer EJ, Wilson JS, Fernandez-Vina M, et al. A high panel-reactive antibody rescue protocol for cross-matchpositive live donor kidney transplants. Transplantation 2000; 70: 1531-6.
22. Montgomery RA, Zachary AA, Racusen LC, et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000; 70: 887-95.
23. Bentall A, Cornell LD, Gloor JM, et al. Five-year outcomes in living donor kidney transplants with a positive crossmatch. Am J Transplant 2013; 13: 76-85.
24. Gloor JM, Winters JL, Cornell LD, et al. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant 2010; 10: 582-9.
25. Orandi BJ, Garonzik-Wang JM, Massie AB, et al. Quantifying the risk of incompatible kidney transplantation: A multicenter study. Am J Transplant 2014; 14: 1573-80.
26. Montgomery RA, Locke JE, King KE, et al. ABO incompatible renal transplantation: A paradigm ready for broad implementation. Transplantation 2009; 87: 1246-55.
27. Montgomery JR, Berger JC, Warren DS, James NT, Montgomery RA, Segev DL. Outcomes of ABO-incompatible kidney transplantation in the United States. Transplantation 2012; 93: 603-9.
28. Berger JC, Muzaale AD, James N, et al. Living kidney donors ages 70 and older: recipient and donor outcomes. Clin J Am Soc Nephrol 2011; 6: 2887-93.
29. Muzaale AD, Massie AB, Wang MC, et al. Risk of end-stage renal disease following live kidney donation. JAMA 2014; 311: 579-86.
30. Orandi BJ, Chow EHK, Hsu A, et al. Quantifying renal allograft loss following early antibody-mediated rejection. Am J Transplant, 2015; 15: 489-98.
31. Segev DL, Muzaale AD, Caffo BS, et al. Perioperative mortality and long-Term survival following live kidney donation. JAMA 2010; 303: 959-66.
32. Van Arendonk KJ, Orandi BJ, James NT, Segev DL, Colombani PM. Living unrelated renal transplantation: A good match for the pediatric candidate? J Pediatr Surg 2013; 48: 1277-82.
33. Rao JNK, Scott AJ. On chi-squared tests for multiway contingency-Tables with cell proportions estimated from survey data. Ann Stat 1984; 12: 46-60.
34. Wilcox RR. A note on the Theil-Sen regression estimator when the regressor is random and the error term is heteroscedastic. Biom J 1998; 40: 261-8.
35. Newson R. Parameters behind "nonparametric" statistics: Kendalls tau, Somers D and median differences. Stata J 2002; 2: 45-64.
36. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York: Springer Science & Business Media, 2000.
37. Reed EF, Rao P, Zhang Z, et al. Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant 2013; 13: 1859-70.
38. Tait BD, Sal C, Gebel HM, et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation 2013; 95: 19-47.
39. Zachary AA, Klingman L, Thorne N, Smerglia AR, Teresi GA. Variations of the lymphocytotoxicity test. An evaluation of sensitivity and specificity. Transplantation 1995; 60: 498-503.
40. Zachary AA, Lucas DP, Detrick B, Leffell MS. Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution. Hum Immunol 2009; 70: 496-501.